Locus Biosciences—a clinical-stage biotech developing a new class of CRISPR-based antibacterial drugs—just closed a $35 million financing round with backing from Johnson & Johnson. The $35 million ...
Image courtesy by QUE.com The logistics landscape is evolving at breakneck speed, driven by surging e‑commerce demand, labor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results